Endonovo Therapeutics, Inc. Liquidation Value
ENDV
Other
Cash & Equivalents
$0
As of 2023-09-30
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $0
Total Obligations: -$30.78M
$-30.78M
Per share: $-0.10
Period: 2023-09-30
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $0
AR: $0
Total Obligations: -$30.78M
$-30.78M
Per share: $-0.10
Period: 2023-09-30
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $0
AR: $0
Inventory: $0
Total Obligations: -$30.78M
$-30.78M
Per share: $-0.10
Period: 2023-09-30
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-30.78M | $-0.10 |
| Liquid Liquidation Value | $-30.78M | $-0.10 |
| Operating Liquidation Value | $-30.78M | $-0.10 |
Key Components (as of 2023-09-30)
| Cash & Equivalents | $0 |
| Accounts Receivable | $3,120 |
| Inventory | N/A |
| Current Liabilities | $23.70M |
| Long-term Debt | $7.09M |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 318.8M |
Explore all 0 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0 | N/A | N/A | N/A | $23.70M | $7.09M | N/A | N/A |
| 2023-06-30 | $32,602 | N/A | N/A | N/A | $23.14M | $7.05M | N/A | N/A |
| 2023-03-31 | $10,942 | $3,120 | N/A | N/A | $25.49M | $6.90M | N/A | N/A |
| 2022-12-31 | $98 | N/A | N/A | $884,195 | $33.38M | $7.15M | N/A | N/A |
| 2022-09-30 | $23,139 | $944 | N/A | $865,753 | $20.98M | $7.27M | N/A | N/A |
| 2022-06-30 | $0 | $945 | N/A | $786,032 | $20.68M | $7.41M | N/A | N/A |
| 2022-03-31 | $59,982 | $945 | N/A | $704,018 | $19.77M | $7.35M | N/A | N/A |
| 2021-12-31 | $85,936 | $944 | N/A | $658,463 | $17.70M | $7.26M | N/A | N/A |
▼ Community Notes